Foundayo

Foundayo is a new weight-loss pill developed by pharmaceutical company Eli Lilly. The U.S. Food and Drug Administration (FDA) has granted speedy approval for its use in treating obesity. Manufacturing of Foundayo is taking place at a plant in Carolina, Puerto Rico. This development is significant as it introduces a new oral medication option for weight management, potentially complementing or offering an alternative to injectable treatments. While another GLP-1 based weight-loss drug, Wegovy (semaglutide), has recently gone on sale in the UK, Foundayo represents a distinct product from a different manufacturer, Eli Lilly, and its FDA approval marks a key milestone in its availability for the U.S. market. The pill's approval highlights ongoing advancements in the pharmaceutical industry's efforts to address the growing public health concern of obesity.